[Eosinophilia myalgia syndrome, toxic oil syndrome].
Niiyama
T
T
Third Department of Internal Medicine, Kagoshima University.
Higuchi
I
I
D000814:Aniline Compounds / Q000009:adverse effects / Q000032:analysis; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects; D003937:Diagnosis, Differential; D004042:Dietary Fats, Unsaturated; D016603:Eosinophilia-Myalgia Syndrome / Q000209:etiology / Q000503:physiopathology; D005506:Food Contamination / Q000032:analysis; D006801:Humans; D011379:Prognosis; D013256:Steroids; D014364:Tryptophan / Q000009:adverse effects
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D018687:Antidepressive Agents, Second-Generation; D004042:Dietary Fats, Unsaturated; D013256:Steroids; D014364:Tryptophan; C023650:aniline